Development of an AmpliSeq^TM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain

Abstract

Background: Many gene variants modulate the individual perception of pain and possibly also its persistence. The limited selection of single functional variants is increasingly being replaced by analyses of the full coding and regulatory sequences of pain-relevant genes accessible by means of next generation sequencing (NGS).

Methods: An NGS panel was created for a set of 77 human genes selected following different lines of evidence supporting their role in persisting pain. To address the role of these candidate genes, we established a sequencing assay based on a custom AmpliSeq^TM panel to assess the exomic sequences in 72 subjects of Caucasian ethnicity. To identify the systems biology of the genes, the biological functions associated with these genes were assessed by means of a computational over-representation analysis.

Results: Sequencing generated a median of 2.85 ⋅ 10⁶ reads per run with a mean depth close to 200 reads, mean read length of 205 called bases and an average chip loading of 71%. A total of 3,185 genetic variants were called. A computational functional genomics analysis indicated that the proposed NGS gene panel covers biological processes identified previously as characterizing the functional genomics of persisting pain.

Conclusion: Results of the NGS assay suggested that the produced nucleotide sequences are comparable to those earned with the classical Sanger sequencing technique. The assay is applicable for small to large-scale experimental setups to target the accessing of information about any nucleotide within the addressed genes in a study cohort.

Introduction

Persisting pain has been proposed to result from a gene environment interaction where nerve injuries or inflammatory processes act as triggers while the clinical symptoms develop only in a minority of subjects (Lee and Tracey, 2013). A role of the genetic background in pain is supported by evidence of many variants modulating the individual perception of pain and the development of its persistence (Diatchenko et al., 2005; Lötsch et al., 2009b; Mogil, 2012). Genetic variants have been reported to confer protection against pain such as the rs1799971 variant in the μ-opioid receptor gene (OPRM1) (Lötsch et al., 2006), or to increase the risk for persisting pain such as the rs12584920 variant of the 5-hydroxytryptamine receptor 2A gene (HTR2A) (Nicholl et al., 2011) or the rs734784 polymorphism in the voltage-gated potassium ion channel modifier, subfamily S member 1, gene (KCNS1) (Costigan et al., 2010). Nevertheless, the genetic background of persisting pain is still incompletely understood (Mogil, 2009; Lötsch and Geisslinger, 2010) and under intense discussion.

Until recently, research focused on the role of selected functional genetic variants as protective or risk factors of persisting pain. This has changed with the broader availability of next generation sequencing (NGS) (Metzker, 2010). To make use of these technical advancements, we developed a custom AmpliSeq^TM library and sequencing assay for efficient detection of genetic variants possibly associated with persisting pain. We propose an assay of a set of 77 genes supported by evidence of an involvement in pain and its development toward persistence. The set size fully uses the technical specifications of the AmpliSeq^TM gene sequencing library technique.

Materials and Methods

Selection of Genes Relevant for Persisting Pain

A set of candidate genes with shown or biologically plausible relevance to persisting pain was created by applying a combination of criteria, which provided three different genetic subsets. Subset 1 was chosen exclusively on the basis of computational functional genomics based on a recently published analysis of persisting pain regarded as displaying systemic features of learning and neuronal plasticity (Mansour et al., 2014). As discussed previously (Ultsch et al., 2016), the view of chronic pain as a dysregulation in biological processes of learning and neuronal plasticity (Alvarado et al., 2013) seems to be captured by the controlled vocabulary (Camon et al., 2004) of the Gene Ontology (GO) knowledge base by the GO terms “learning or memory” (GO:0007611)¹ and “nervous system development” (GO:0007399)². An intersection of the genes annotated to these GO terms with a set of 539 “pain genes” identified empirically as relevant to pain provided the first subset of 34 genes described in detail previously (Ultsch et al., 2016). Briefly, the intersecting set of so-called “pain genes” consists of a combination of (i) genes listed in the PainGenes database (Lacroix-Fralish et al., 2007)³, (ii) genes causally involved in human hereditary diseases associated with extreme pain phenotypes, (iii) genes found to be associated with chronic pain in at least three human studies, and (iv) genes coding for targets of novel analgesics under clinical development (Lötsch et al., 2013).

Subset 2 consisted of genes that were reported to carry variants modulating the risk or the phenotypic symptoms in at least two different clinical settings of persisting pain. They were obtained using (i) a PubMed database search for the string “(chronic OR persisting OR neuropathic OR back OR inflammatory OR musculoskeletal OR visceral OR widespread OR idiopathic OR fibromyalgia) AND pain AND (polymorphism OR variant) NOT review,” to which genes highlighted in overviews on pain genetics (e.g., Edwards, 2006) were added. The intersection of the queried genes with the set of 539 “pain genes” (see above) provided a subset of 13 genes (Table 1).

Finally, subset 3 comprised genes that have consistently been included in human pain research projects over the last several years. One of them is the OPRM1 gene that codes for the human μ-opioid receptor and which has been shown to modulate the time course of persisting cancer pain by delaying the necessity of opioid treatment (Lötsch et al., 2010). However, further genes were added such as the GDNF gene coding for the glial cell derived neurotrophic factor, which has been shown to be involved in a glia-dependent mechanism of neuropathic pain (Wang et al., 2014) although no modulating human genetic variants have been reported so far. Following expert counseling within the EU-funded “glial-opioid interface in chronic pain, GLORIA” research consortium (Kringel and Lötsch, 2015)⁴, a subset of 30 genes (Table 1) was identified. Thus, the complete set as the union of the three subsets comprised 43 + 13 + 30 = 77 genes that are proposed to be included in an NGS panel of human persisting pain.

DNA Sample Origin

Due to the costs of assay development (for details, see second paragraph of the Discussion), the Ampliseq^TM panel was established in a limited number of n = 72 DNA samples. This corresponds to the number of samples used in comparable recent studies for NGS assay establishment and validation (Bruera et al., 2018; De Luca et al., 2018; Mustafa et al., 2018; Shah et al., 2018). To further limit the project costs, the Ampliseq^TM panel was established in a subset of samples originating from a clinical cohort of 1,000 women who had undergone breast cancer surgery (Kaunisto et al., 2013; Lötsch et al., 2018). The study followed the Declaration of Helsinki and was approved by the Coordinating Ethics Committee of the Helsinki University Hospital. Each participating subject had provided a written informed consent including genetic studies.

Specifically, for the presently reported method establishment, a subsample of 72 women (age 58.4 ± 8 years, mean ± standard deviation, weight 69.3 ± 11 kg), was drawn from the clinical subgroup not having developed persisting pain during the observation period. This was believed to come closer to a random sample than a mixture of patients with persisting and without persisting pain. This limitation of the sample selection has probably affected which and how many variants were identified. However, it is unlikely to have jeopardized the general applicability of the gene selection heuristics, assay establishment and validation, and of the functional analysis of the selected subset of genes.

DNA Template Preparation and Amplification

A multiplex PCR amplification strategy for the coding gene sequences was accomplished online (Ion Ampliseq^TM Designer)⁵ to amplify the target region specified above (for primer sequences, see Supplementary Table 1) with 25 base pair exon padding. After a comparison of several primer design options, the design providing the maximum target sequence coverage was chosen. The ordered 1,953 amplicons covered approximately 97.5% of the target sequence (Supplementary Table 2). A total of 10 ng DNA per sample was used for the target enrichment by a multiplex PCR and each DNA pool was amplified with the Ion Ampliseq^TM Library Kit in conjunction with the Ion Ampliseq^TM “custom Primer Pool”-protocols according to the manufacturer’s procedures (Life Technologies, Darmstadt, Germany).

After each pool had undergone 18 PCR cycles, the PCR primers were removed with FuPa Reagent and the amplicons were ligated to the sequencing adaptors with short stretches of index sequences (barcodes) that enabled sample multiplexing for subsequent steps (Ion Xpress^TM Barcode Adapters Kit; Life Technologies). After purification with AMPure XP beads (Beckman Coulter, Krefeld, Germany), the barcoded libraries were quantified with a Qubit^® 2.0 Fluorimeter (Life Technologies, Darmstadt, Germany) and normalized for DNA concentration to a final concentration of 20 pmol/l using the Ion Library Equalizer^TM Kit (Life Technologies, Darmstadt, Germany). Equalized barcoded libraries from seven to eight samples at a time were pooled. To clonally amplify the library DNA onto the Ion Sphere Particles (ISPs; Life Technologies, Darmstadt, Germany), the library pool was subjected to emulsion PCR by using an Ion PGM HI-Q View Template Kit on an PGM OneTouch system (Life Technologies, Darmstadt, Germany) following the manufacturer’s protocol.

Sequencing

Enriched ISPs which carried many copies of the same DNA fragment were subjected to sequencing on an Ion 318 Chip to sequence pooled libraries with seven to eight samples. During this process, bases are inferred from light intensity signals, a process commonly referred to as base-calling (Ledergerber and Dessimoz, 2011). The number of combined libraries that can be accommodated in a single sequencing run depends on the size of the chip, the balance of barcoded library concentration, and the coverage required. The high-capacity 318 chip was chosen (instead of the low-capacity 314 or the medium-capacity 316 chip) to obtain a high sequencing depth of coverage for a genomic DNA library with >95% of bases at 30x. Sequencing was performed using the sequencing kit (Ion PGM Hi-Q Sequencing Kit; Life Technologies, Darmstadt, Germany) as per the manufacturer’s instructions with the 200 bp single-end run configuration. This kit contained the most advanced sequencing chemistry available to users of the Ion PGM System (Life Technologies, Darmstadt, Germany).

Data Analysis

Bioinformatics Generation of Sequence Information

The raw data (unmapped BAM-files) from the sequencing runs were processed using Torrent Suite Software (Version 5.2.2, Life Technologies, Darmstadt, Germany) to generate read alignments which were filtered by the software into mapped BAM-files using the reference genomic sequence (hg19) of target genes. Variant calling was performed with the Torrent Variant Caller Plugin using as key parameters: minimum allele frequency = 0.15, minimum quality = 10, minimum coverage = 20 and minimum coverage on either strand = 3.

The annotation of called variants was done using the Ion Reporter Software (Version 4.4; Life Technologies, Darmstadt, Germany) for the VCF files that contained the nucleotide reads and the GenomeBrowse^® software (Version 2.0.4, Golden Helix, Bozeman, MT, United States) to map the sequences to the reference sequences GRCh37 hg19 (dated February 2009). The SNP and Variation Suite software (Version 8.4.4; Golden Helix, Bozeman, MT, United States) was used for the analysis of sequence quality, coverage and for variant identification.

Based on the observed allelic frequency, the expected number of homozygous and heterozygous carriers of the respective SNP (single nucleotide polymorphism) was calculated using the Hardy-Weinberg equation. Only variants within the Hardy-Weinberg equilibrium as assessed using Fisher’s exact test (Emigh, 1980) were retained. The SNP and Variation Suite software (Version 8.4.4; Golden Helix, Bozeman, MT, United States) was used for the analysis of sequence quality, coverage and for variant identification.

Assay Validation

Method validation was accomplished by means of Sanger sequencing (Sanger and Coulson, 1975; Sanger et al., 1977) in an independent external laboratory (Eurofins Genomics, Ebersberg, Germany). As performed previously with different AmpliSeq^TM panels (Kringel et al., 2017) and other genotyping assays (Skarke et al., 2004, 2005), four DNA samples have been chosen randomly from an independent cohort of healthy subjects and sequenced with the current NGS panel. For the detected variant type, single nucleotide polymorphisms from five different genomic regions for which clinical associations have been reported (Table 2), i.e., rs324420 (FAAH), rs333970 (CSF1), rs4986790 (TLR4), rs4633 (COMT), and rs17151558 (RELN) were chosen for external sequencing. Amplification of the respective DNA segments was done using PCR primer pairs (forward, reverse) of (i) 5′-TTTCTTAAAAAGGCCAGCCTCCT-3′ and 5′-AATGACCCAAGATGCAGAGCA-3′ (ii) 5′-GCCTTCAACCCCGGGATGG-3′ and 5′-CTCCGATCCCTGGTGCTCCTC-3′ (iii) 5′-TTTATTGCACAGACTTGCGGGTTC-3′ and 5′-AGCCTTTTGAGAGATTTGAGTTTCA-3′ (iv) 5′-CCTTATCGGCTGGAACGAGTT-3′ and 5′-GTAAGGGCTTTGATGCCTGGT-3′ (v) 5′-GTTATTCCTCTGTAAGCAGCTGCCT-3′ and 5′-TGTTTGTTTTAGATTGTGGTGGGTT-3′. Results of Sanger sequencing were aligned with the genomic sequence and analyzed using Chromas Lite^® (Version 2.1.1, Technelysium Pty Ltd, South Brisbane, QLD, Australia) and the GenomeBrowse^® (Version 2.0.4, Golden Helix, Bozeman, MT, United States) was used to compare the sequences obtained with NGS or Sanger techniques.

Results

The NGS assay of the proposed set of 77 human genes relevant to persisting pain was established in 72 genomic DNA samples. As applied previously (Kringel et al., 2017), only exons including 25 bases of padding around all targeted coding regions for which the realized read-depths for each nucleotide was higher than 20 were contemplated as successfully analyzed. With this acceptance criterion the whole or almost whole coverage of the relevant sequences was obtained (Table 1; for details on missing variants, see Supplementary Table 3). The NGS sequencing process of the whole patient cohort required ten separate runs, each with samples of n = 7 or n = 8 patients. Coverage statistics were analogous between all runs and matched the scope of accepted quality levels [20–22]. A median of 2.85 ⋅ 10⁶ reads per run was produced. The mean depth was close to 200 reads, the mean read length of called bases resulted in 205 bases and average chip loading was 71% (Figure 1A). To establish a sequencing output with a high density of ISPs on a sequencing chip, the chip loading value should exceed 60% (Life Technologies, Carlsbad, United States). The generated results of all NGS runs matched with the results obtained with Sanger sequencing of random samples (Figure 1B), meaning the accordance of nucleotide sequences between NGS and Sanger sequencing was 100% in all validated samples.

FIGURE 1

Following elimination of nucleotides agreeing with the standard human genome sequence GRCh37 g1k (dated February 2009), the result of the NGS consisted of a vector of nucleotide information about the d = 77 genes for each individual DNA sample (Figure 2). This vector had a length equaling the set union of the number of chromosomal positions in which a non-reference nucleotide had been found in any probe of the actual cohort. Specifically, a total of 3,185 genetic variants was found, of which 659 were located in coding parts of the genes, 1,241 were located in introns and 1,285 in the 3′-UTR, 5′-UTR, upstream or downstream regions. The coding variants for which a clinical or phenotypic association have been reported are listed in Table 2 together with an example of each variant. Most of the observed variants were single nucleotide polymorphisms (d = 571) whereas mixed polymorphisms (d = 26), nucleotide insertions (d = 18) or nucleotide deletions (d = 44) were more rarely found.

FIGURE 2

Discussion

In this report, development and validation of a novel Ampliseq^TM NGS assay for the coding regions and boundary parts of d = 77 genes qualifying as candidate modulators of persisting pain is described. The NGS assay produced nucleotide sequences that corresponded, with respect to the selected validation probes, to the results of classical Sanger sequencing. However, the NGS assay substantially reduced the laboratory effort to obtain the genetic information and provides the perquisites to be used in high throughput environments. In particular, the presented NGS assay is convenient for small up to large-scale setups. As mentioned in the methods section, a limitation of the present results applies to the identified genetic variants as only samples from Caucasian women were included. By contrast, the validity of gene selection and assay establishment is unlikely to be reduced by this selection chosen to remain within the financial limits of the present project.

Specifically, as observed previously (Kringel et al., 2017), the comprehensive genetic information and the high throughput are reflected in the assay costs. Specifically, sequencing of the 77 genes in 72 DNA samples required approximately € 18,000 for the AmpliSeq^TM custom panel, € 5,500 for library preparation, € 700 for template preparation and € 700 for sequencing. Ten 318 sequencing chips cost around € 7,000 and in addition and basic consumables and laboratory supplies issued approximately € 800. With 7–8 barcoded samples loaded on ten chips, the expense to analyses the gene sequence for a single patient were around € 325. While NGS costs are likely to decrease in the near future (Lohmann and Klein, 2014), present assay establishment was therefore applied in DNA samples planned for future genotype versus phenotype association analysis, which required using DNA from patients of a pain-relevant cohort instead from a true random sample of healthy subjects.

As a result of the present assay development, a set of d = 77 genes was chosen as potentially relevant to persisting pain. The chosen set of genes differs from alternative proposals aiming at similar phenotypes (Mogil, 2012; Zorina-Lichtenwalter et al., 2016). However, when analyzing these alternatives for mutual agreement, only limited overlap could be observed (Figure 3). This emphasizes that the genetic architecture of persisting pain is incompletely understood, and several independent lines of research can be pursued. Of note, the present set showed the largest agreement with a set of d = 539 genes identified empirically as relevant to pain and listed in the PainGenes database (Lacroix-Fralish et al., 2007)⁶ or recognized as causing human hereditary diseases associated with extreme pain phenotypes (Lötsch et al., 2013; Ultsch et al., 2016). Combining all proposals into a large panel was not an option due to the technical limitations of the IonTorrent restricting the panel size to 500 kb (pipeline version 5.6.2); therefore, further genes would need to be addressed in separate panels.

FIGURE 3

In the present study sample, selected with a certain bias by using, as explained above for cost saving, clinical samples from only women and only Caucasians, a total of 659 genetic coding variants were found. Regardless of the sample preselection, 105 clinical associations (Table 2) could be queried for the observed variants from openly obtainable data sources comprising (i) the Online Mendelian Inheritance in Man (OMIM^®) database⁷, (ii) the NCBI gene index database⁸, the GeneCards database⁹ [27] and the “1000 Genomes Browser”¹⁰ (all accessed in December 2017). The observation of functional variants in the present cohort preselected for the absence of pain persistence is plausible as (i) variants can exert protective effects against chronic pain and (ii) most genetic variants identified so far exert only small effects on pain and the individual result of their functional modulations depends on their combined effects or from the sum of positive and negative effects on pain perception (Lötsch et al., 2009a).

The selection of genes (Table 1) relied on empirical evidence of their involvement in pain. For subset #1 (d = 34), this had been shown for 33 genes in the original paper (Ultsch et al., 2016). As the hypothesis that persisting pain displays systemic features of learning and of neuronal plasticity (Mansour et al., 2014) could be substantiated at a computational functional genomics level, the further gene (PTPRZ1, protein tyrosine phosphatase Z 1) can also be regarded as supported by prior knowledge to be included in the present set. The subset comprised, for example, genes associated with the mesolimbic dopaminergic system, i.e., DRD1, DRD2, DRD3, which code for dopamine receptors, and TH, which is the coding gene for the tyrosine hydroxylase, a metabolic restricting enzyme in dopaminergic pathways, which have been implicated in promoting chronic back pain (Hagelberg et al., 2003, 2004; Jaaskelainen et al., 2014; Martikainen et al., 2015). Further 14 genes were involved in the circadian rhythm recognized as a modulatory factor in various pain conditions such as arthritis (Haus et al., 2012; Gibbs and Ray, 2013) and neuropathic pain (Gilron and Ghasemlou, 2014). The subset further included three NMDA receptor genes (GRIN1, GRIN2A, and GRIN2B) known to be major players in a number of essential physiological functions including neuroplasticity (Coyle and Tsai, 2004). In addition, metabotropic glutamate receptors (mGluR) have been implemented in several chronic pain conditions. One subtype, mGluR5, coded by GRM5, is of particular interest in the context of pain conditions as recent studies showed a pro-nociceptive role of mGluR5 in models of chronic pain (Walker et al., 2001; Crock et al., 2012). Furthermore, genes associated with histaminergic signaling such as HRH3 have been implicated in pain transmission (Hough and Rice, 2011) and analgesia (Huang et al., 2007).

The second subset of genes relied on a new PubMed search rather than on a previously published and hypothesis-based selection of candidate genes. A computational functional genomics analysis of this subset (details not shown) suggested its involvement in (i) immune processes and (ii) nitric oxide signaling. The genes annotated to the GO term “immune system process” included interleukin (IL1B, IL4, IL6, IL10) (Dinarello, 1994; Choi and Reiser, 1998; Mocellin et al., 2004; Nemeth et al., 2004) and histocompatibility complex related (HLA-B) genes (Dupont and Ceppellini, 1989), which have been shown to be involved in immunological mechanisms of pain (Sato et al., 2002; de Rooij et al., 2009). This is also supported by published evidence for the further genes in this list, such as, TNF (Vassalli, 1992; Franchimont et al., 1999), GCH1 (Schott et al., 1993) and P2RX7 (Chen and Brosnan, 2006). The second major process group emerging from the functional genomics analysis of the key evidence for genetic modulation of clinical chronic pain was nitric oxide signaling, in particular metabolic processes, summarized in this context under the GO term “reactive oxygen species metabolic process” which includes the genes IL6 (Deakin et al., 1995), TNF (Deakin et al., 1995; Katusic et al., 1998), ESR1 (Clapauch et al., 2014), IL10 (Cattaruzza et al., 2003), GCH1 (Katusic et al., 1998; Zhang et al., 2007), IL1B (Katusic et al., 1998), IL4 (Coccia et al., 2000), P2RX7 (Gendron et al., 2003), SOD2 (Fridovich, 1978). Furthermore, catecholamines including noradrenaline, adrenaline and dopamine have multiple functions in the brain and spinal cord including pain perception and processing (D’Mello and Dickenson, 2008). Catechol-O-methyltransferase, encoded by the COMT gene, is one of several enzymes that degrade dopamine, noradrenaline and adrenaline and has become one of the most frequently addressed genes in pain research (Nackley et al., 2006).

Finally, subset #3 (d = 30) consists of genes repeatedly shown to play a role in the genetic modulation of persisting pain in humans or, by contrast, included a few novel items only recently published in the context of pain. This included members of the transient receptor potential (TRP) family (TRPA1, TRPM8, TRPV4) that are expressed at nociceptors and which are well established players in the perception of pain via their excitation by chemical, thermal or mechanical stimuli (Clapham, 2003). This similarly applies to the opioidergic system represented by the inclusion of the genes coding for the major opioid receptors (OPRM1, OPRK1 OPRD1), which have been associated with variations in pain or opioid response in various settings (Lötsch and Geisslinger, 2005). The most important of this group, the μ-opioid receptor encoded by the OPRM1 gene, carriers several variants of which the 118 A>G (rs1799971) has been studied most extensively since the early description of its association with a functional phenotype in humans (Lötsch et al., 2002).

Almost half of the present sets of genes were chosen based on a computational functional genomics analysis that attributed persisting pain to GO processes of “learning or memory” and “nervous system development” (Ultsch et al., 2016) as likely to reflect systemic features of persisting pain. This implied a functional bias and therefore, the present set of d = 77 genes (Figure 4) was analyzed whether this bias prevailed when comparing it with the alternative sets of human genes proposed to modulate persisting pain (Mogil, 2012; Zorina-Lichtenwalter et al., 2016). As applied previously (Lippmann et al., 2018), the biological roles of the set of d = 77 genes were queried from the Gene Ontology knowledgebase (GO)¹¹ (Ashburner et al., 2000) where the knowledge about the biological processes, the molecular functions and the cellular components of genes is formulated using a controlled and clearly defined vocabulary of GO terms. Particular biological roles of the set of d = 77 genes, among all human genes, were analyzed by means of over-representation analysis (ORA). This compared the occurrence of the particular GO terms associated with the present set of genes with their expected occurrence by chance (Backes et al., 2007). In contrast to enrichment analysis, any quantitative criteria such as gene expression values are disregarded (Backes et al., 2007). The analyses were performed using our R library “dbtORA” (Lippmann et al., 2018)¹² on the R software environment (version 3.4.2 for Linux; R Development Core Team, 2008)¹³.

FIGURE 4

Surprisingly, the results of this analysis indicated that the functional bias of the present gene set toward “learning or memory” (GO:0007611) and “nervous system development” (GO:0007399) was not maintained against the alternative gene sets. Instead, a few more general GO terms such as “behavior” (“single organism behavior,” GO:0044708), or “response to organic cyclic compound” (GO:0014070) and response to alkaloid (GO:0043279), which could be identified as morphine and cocaine when repeating the analysis with a less conservative α-correction (further details not shown), were overrepresented, as well as the pain specific term “sensory perception of pain” (GO:0019233). A possible explanation that the selection bias of the present gene set was not maintained when comparing it with alternative proposals is that the two biological processes, “learning or memory” and “nervous system development,” reflect indeed an important biological function of persisting pain and even when choosing candidate genes without having these processes in mind as for the alternative gene sets, they are nevertheless included. This may be regarded as support for the present gene set as suitable candidates for future association studies with persisting pain phenotypes.

Although the present gene set has been assembled with a focus of a relevance to pain, many of its members have pharmacological implications. Specifically, 58 of the 77 genes (75%) have been chosen as targets of analgesics, approved or under current clinical development (Table 3). Moreover, several of the genes in the present NGS panel have been implicated in pharmacogenetic modulations of drug effects (Table 4). Possibly the most widely studied gene in analgesic research is OPRM1 because coding for the primary target of opioids (Peiro et al., 2016). Several polymorphisms have been described in OPRM1, among which the best characterized may be rs1799971 (OPRM1 118A>G) that leads to an asparagine to aspartate substitution at the extracellular terminal of the receptor protein (Bond et al., 1998). May studies have addressed this variant (for reviews, see Walter et al., 2013; Somogyi et al., 2015). Summarizing its effects, the variant is associated with decreased receptor expression and signaling efficiency (Oertel et al., 2012) which leads to reproducibly reduced pharmacodynamic effects in human experimental settings while the effect size seems insufficient to be a major factor of opioid response in clinical settings, despite several reports of modulations of opioid demands or side effects. For example, subjects carrying the 118A>G variant were found to have a reduced response to morphine treatment (Hwang et al., 2014), reduced analgesic response to alfentanil (Oertel et al., 2006) and demanded higher doses of morphine for pain relief (Klepstad et al., 2004; Hwang et al., 2014). However, the importance of this variant seems to be comparatively high in patients with an Asian ethnic background, which might be related to the higher allelic frequency as compared to other ethnicities. COMT is a key modulator of dopaminergic neurotransmission and in the signaling response to opioids The Val158Met polymorphism (rs4680) causes an amino acid substitution in the enzyme, which reduced the enzyme active to a forth (Peiro et al., 2016). Carriers of the homozygous Met/Met variant had lower morphine requirements than those with a the wild type COMT (Rakvag et al., 2005). Furthermore, a modulation of the effects of TRPV1 targeting analgesics is supported by observations that intronic TRPV1 variants were associated with insensitivity to capsaicin (Park et al., 2007) while the coding TRPV1 variant rs8065080 was associated with altered responses to experimentally induced pain(Kim et al., 2004). Moreover, gain-of-function mutations in TRPV1 have been associated with increased pain sensitivity (Boukalova et al., 2014), for which TRPV1 antagonists would enable a specific pharmacogenetics-based personalized cure.

Conclusion

The breakthrough in mapping the whole human genome (Lander et al., 2001; Venter et al., 2001) along with genome wide association studies (GWAS) has led to rapid advances in the knowledge of the genetic bases of human diseases (Wellcome Trust Case Control and Consortium, 2007). Genetic research in pain medicine has directed to the recognition of genes in which variants influence pain behavior, post-operative drug requirements, and the temporal developments of pain toward persistence (James, 2013). While many candidate gene association studies have identified multiple genes relevant for pain phenotypes (Fillingim et al., 2008), pain related genetic studies have so far been owned by investigations of a limited number of genes. Roughly ten genes or gene complexes account for over half of the extant findings and several of these candidate gene associations have held up in replication (Mogil, 2012). The selection of variants has been limited and they have been addressed in most studies repeatedly, leading to the perception that genetic research in pain produces often unsatisfactory results (Mogil, 2009). However, this may soon change with the arise of new technologies. In this manuscript, we present a validated NGS assay for a set of 77 genes supported by empirical evidence and computational functional genomics analyses as relevant factors modulating the risk for persisting pain or its clinical picture.

References

• 1

  AbbadieC.BessonJ. M.CalvinoB. (1994). c-Fos expression in the spinal cord and pain-related symptoms induced by chronic arthritis in the rat are prevented by pretreatment with Freund adjuvant.J. Neurosci.145865–5871. 10.1523/JNEUROSCI.14-10-05865.1994

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2

  AchkarJ.-P.KleiL.De BakkerP. I. W.BelloneG.RebertN.ScottR.et al (2012). Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis.Genes Immun.13245–252. 10.1038/gene.2011.79

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 3

  Al-EitanL. N.JaradatS. A.SuS. Y.TayG. K.HulseG. K. (2012). Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent.Pharmgen. Pers. Med.599–111. 10.2147/PGPM.S33351

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 4

  AlvaradoS.TajerianM.MillecampsM.SudermanM.StoneL. S.SzyfM. (2013). Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex.Mol. Pain9:21. 10.1186/1744-8069-9-21

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5

  AndreoliV.De MarcoE. V.TrecrociF.CittadellaR.Di PalmaG.GambardellaA. (2014). Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease.J. Neural Transm. (Vienna)121533–542.

  • Pubmed Abstract
  • Google Scholar

• 6

  AshburnerM.BallC. A.BlakeJ. A.BotsteinD.ButlerH.CherryJ. M.et al (2000). Gene ontology: tool for the unification of biology.Gene Ontol. Consortium. Nat. Genet.2525–29. 10.1038/75556

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7

  BackesC.KellerA.KuentzerJ.KneisslB.ComtesseN.ElnakadyY. A.et al (2007). GeneTrail–advanced gene set enrichment analysis.Nucleic Acids Res.35W186–W192. 10.1093/nar/gkm323

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 8

  BiesiadaJ.ChidambaranV.WagnerM.ZhangX.MartinL. J.MellerJ.et al (2014). Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.Pharmacogenomics151749–1762. 10.2217/pgs.14.137

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 9

  BondC.LaforgeK. S.TianM.MeliaD.ZhangS.BorgL. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.Proc. Natl. Acad. Sci. U.S.A.959608–9613. 10.1073/pnas.95.16.9608

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 10

  BoukalovaS.TouskaF.MarsakovaL.HynkovaA.SuraL.ChvojkaS.et al (2014). Gain-of-function mutations in the transient receptor potential channels TRPV1 and TRPA1: how painful?Physiol. Res.63(Suppl. 1)S205–S213.

  • Google Scholar

• 11

  BourinetE.AltierC.HildebrandM. E.TrangT.SalterM. W.ZamponiG. W. (2014). Calcium-permeable ion channels in pain signaling.Physiol. Rev.9481–140. 10.1152/physrev.00023.2013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 12

  BravoL.Torres-SanchezS.Alba-DelgadoC.MicoJ. A.BerrocosoE. (2014). Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats.Eur. Neuropsychopharmacol.24996–1003. 10.1016/j.euroneuro.2014.01.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 13

  Bravo-HernándezM.CorletoJ. A.Barragán-IglesiasP.González-RamírezR.Pineda-FariasJ. B.FelixR.et al (2016). The α5 subunit containing GABAA receptors contribute to chronic pain.Pain157613–626. 10.1097/j.pain.0000000000000410

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 14

  BrueraG.PepeF.MalapelleU.PisapiaP.MasA. D.Di GiacomoD.et al (2018). KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy.Oncotarget926279–26290. 10.18632/oncotarget.25180

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15

  BuchheitT.Van De VenT.ShawA. (2012). Epigenetics and the transition from acute to chronic pain.Pain. Med.131474–1490. 10.1111/j.1526-4637.2012.01488.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16

  BuskilaD.CohenH.NeumannL.EbsteinR. P. (2004). An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits.Mol. Psychiatry9730–731. 10.1038/sj.mp.4001568

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17

  CajanusK.HolmströmE. J.WessmanM.AnttilaV.KaunistoM. A.KalsoE. (2016). Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer.Pain157361–369. 10.1097/j.pain.0000000000000398

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18

  CamilleriM.KleeE. W.ShinA.CarlsonP.LiY.GroverM.et al (2014). Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.Am. J. Physiol. Gastrointest. Liver Physiol.306G13–G26. 10.1152/ajpgi.00294.2013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19

  CamonE.MagraneM.BarrellD.LeeV.DimmerE.MaslenJ.et al (2004). The gene ontology annotation (GOA) database: sharing knowledge in uniprot with Gene Ontology.Nucleic Acids Res.32D262–D266. 10.1093/nar/gkh021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 20

  CargninS.VianaM.SancesG.BianchiM.GhiottoN.TassorelliC.et al (2014). Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.Eur. J. Clin. Pharmacol.701195–1202. 10.1007/s00228-014-1726-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 21

  CattaruzzaM.SlodowskiW.StojakovicM.KrzeszR.HeckerM. (2003). Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells.J. Biol. Chem.27837874–37880. 10.1074/jbc.M301670200

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 22

  CeolinL.SiqueiraD. R.RomittiM.FerreiraC. V.MaiaA. L. (2012). Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms.Int. J. Mol. Sci.13221–239. 10.3390/ijms13010221

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 23

  ChattiI.WoillardJ. B.MiliA.CreveauxI.Ben CharfeddineI.FekiJ.et al (2017). Genetic analysis of mu and kappa opioid receptor and COMT enzyme in cancer pain tunisian patients under opioid treatment.Iran J. Public Health461704–1711.

  • Pubmed Abstract
  • Google Scholar

• 24

  ChenC. L.BroomD. C.LiuY.De NooijJ. C.LiZ.CenC.et al (2006). Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.Neuron49365–377. 10.1016/j.neuron.2005.10.036

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25

  ChenD.ZhangT.-L.WangL.-M. (2014). The association of CSF-1 gene polymorphism with chronic periodontitis in the Han Chinese population.J. Periodontol.85e304–e312. 10.1902/jop.2014.130688

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 26

  ChenL.BrosnanC. F. (2006). Regulation of immune response by P2X7 receptor.Crit. Rev. Immunol.26499–513. 10.1615/CritRevImmunol.v26.i6.30

  • CrossRef
  • Google Scholar

• 27

  ChenX.WilliamsonV. S.AnS.-S.HettemaJ. M.AggenS. H.NealeM. C.et al (2008). Cannabinoid receptor 1 gene association with nicotine dependence.Arch. Gen. Psychiatry65816–824. 10.1001/archpsyc.65.7.816

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28

  ChoiP.ReiserH. (1998). IL-4: role in disease and regulation of production.Clin. Exp. Immunol.113317–319. 10.1046/j.1365-2249.1998.00690.x

  • CrossRef
  • Google Scholar

• 29

  ClapauchR.MouraoA. F.MecenasA. S.MaranhaoP. A.RossiniA.BouskelaE. (2014). Endothelial function and insulin resistance in early postmenopausal women with cardiovascular risk factors: importance of ESR1 and NOS3 polymorphisms.PLoS One9:e103444. 10.1371/journal.pone.0103444

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 30

  ClaphamD. E. (2003). TRP channels as cellular sensors.Nature426517–524. 10.1038/nature02196

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 31

  CocciaE. M.StellacciE.MarzialiG.WeissG.BattistiniA. (2000). IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation.Int. Immunol.12977–985. 10.1093/intimm/12.7.977

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 32

  CorominasR.RibasesM.CamiñaM.Cuenca-LeónE.PardoJ.BoronatS.et al (2009). Two-stage case-control association study of dopamine-related genes and migraine.BMC Med. Genet.10:95. 10.1186/1471-2350-10-95

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33

  CoskunS.VarolS.OzdemirH. H.AgacayakE.AydınB.KapanO.et al (2016). Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine.Neuropsychiatr. Dis. Treat.121779–1785. 10.2147/NDT.S108814

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 34

  CostiganM.BelferI.GriffinR. S.DaiF.BarrettL. B.CoppolaG.et al (2010). Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.Brain1332519–2527. 10.1093/brain/awq195

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 35

  CoyleJ. T.TsaiG. (2004). NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia.Int. Rev. Neurobiol.59491–515. 10.1016/S0074-7742(04)59019-0

  • CrossRef
  • Google Scholar

• 36

  CrockL. W.StemlerK. M.SongD. G.AbboshP.VogtS. K.QiuC. S.et al (2012). Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception.Mol. Pain8:20. 10.1186/1744-8069-8-20

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 37

  Davila-FajardoC. L.MarquezA.Pascual-SalcedoD.Moreno RamosM. J.Garcia-PortalesR.MagroC.et al (2014). Confirmation of -174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome.Pharmacogenet. Genom.241–5. 10.1097/FPC.0000000000000013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 38

  De LucaC.RappaA. G.GragnanoG.MalapelleU.TronconeG.BarberisM. (2018). Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.J. Clin. Pathol.71745–750. 10.1136/jclinpath-2018-205197

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 39

  de RooijA. M.Florencia GossoM.HaasnootG. W.MarinusJ.VerduijnW.ClaasF. H.et al (2009). HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia.Pain14582–85. 10.1016/j.pain.2009.05.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 40

  DeakinA. M.PayneA. N.WhittleB. J.MoncadaS. (1995). The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma.Cytokine7408–416. 10.1006/cyto.1995.0056

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 41

  DiatchenkoL.AndersonA. D.SladeG. D.FillingimR. B.ShabalinaS. A.HigginsT. J.et al (2006). Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.Am. J. Med. Genet. B Neuropsychiatr. Genet.141B449–462. 10.1002/ajmg.b.30324

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 42

  DiatchenkoL.SladeG. D.NackleyA. G.BhalangK.SigurdssonA.BelferI.et al (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition.Hum. Mol. Genet.14135–143. 10.1093/hmg/ddi013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 43

  DinarelloC. A. (1994). The biological properties of interleukin-1.Eur. Cytokine Netw.5517–531.

  • Google Scholar

• 44

  DineleyK. T.PandyaA. A.YakelJ. L. (2015). Nicotinic ACh receptors as therapeutic targets in CNS disorders.Trends Pharmacol. Sci.3696–108. 10.1016/j.tips.2014.12.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 45

  D’MelloR.DickensonA. H. (2008). Spinal cord mechanisms of pain.Br. J. Anaesth.1018–16. 10.1093/bja/aen088

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 46

  DoehringA.KirchhofA.LötschJ. (2009). Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.Psychiatr. Genet.19259–268. 10.1097/YPG.0b013e32832d0941

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 47

  DoehringA.KüsenerN.FlührK.NeddermeyerT. J.SchneiderG.LötschJ. (2011). Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures.PLoS One6:e17724. 10.1371/journal.pone.0017724

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 48

  DominguezC. A.KalliomakiM.GunnarssonU.MoenA.SandblomG.KockumI.et al (2013). The DQB1 ^∗03:02 HLA haplotype is associated with increased risk of chronic pain after inguinal hernia surgery and lumbar disc herniation.Pain154427–433. 10.1016/j.pain.2012.12.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 49

  DuanG.GuoS.ZhangY.YingY.HuangP.WangQ.et al (2015). The effect of SCN9A variation on basal pain sensitivity in the general population: an experimental study in young women.J. Pain16971–980. 10.1016/j.jpain.2015.06.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 50

  DupontB.CeppelliniR. (1989). Immunobiology of HLA.New York, NY: Springer-Verlag.

  • Google Scholar

• 51

  DuttaS.GangopadhyayP. K.SinhaS.ChatterjeeA.GhoshS.RajammaU. (2011). An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal.Cell. Mol. Neurobiol.3145–56. 10.1007/s10571-010-9551-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 52

  DziedziejkoV.KurzawskiM.SafranowK.ChlubekD.PawlikA. (2011). The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide.Pharmacogenomics1241–47. 10.2217/pgs.10.164

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 53

  EdwardsR. R. (2006). Genetic predictors of acute and chronic pain.Curr. Rheumatol. Rep.8411–417. 10.1007/s11926-006-0034-2

  • CrossRef
  • Google Scholar

• 54

  EmighT. H. (1980). A comparison of tests for hardy-weinberg equilibrium.Biometrics36627–642. 10.2307/2556115

  • CrossRef
  • Google Scholar

• 55

  ErsigA. L.SchutteD. L.StandleyJ.LeslieE.ZimmermanB.KleiberC.et al (2017). Relationship of genetic variants with procedural pain, anxiety, and distress in children.Biol. Res. Nurs.19339–349. 10.1177/1099800417692878

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 56

  EskolaP. J.KjaerP.DaavittilaI. M.SolovievaS.OkuloffA.SorensenJ. S.et al (2010). Genetic risk factors of disc degeneration among 12-14-year-old danish children: a population study.Int. J. Mol. Epidemiol. Genet.1158–165.

  • Pubmed Abstract
  • Google Scholar

• 57

  FengY.EganB.WangJ. (2016). Genetic factors in intervertebral disc degeneration.Genes Dis.3178–185. 10.1016/j.gendis.2016.04.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 58

  FengY.ZhaoX.ZhouC.YangL.LiuY.BianC.et al (2013). The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).Gene529296–299. 10.1016/j.gene.2013.07.019

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 59

  FillingimR. B.WallaceM. R.HerbstmanD. M.Ribeiro-DasilvaM.StaudR. (2008). Genetic contributions to pain: a review of findings in humans.Oral Dis.14673–682. 10.1111/j.1601-0825.2008.01458.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 60

  FlorioS. K.LohC.HuangS. M.IwamayeA. E.KittoK. F.FowlerK. W.et al (2009). Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.Br. J. Pharmacol.158494–506. 10.1111/j.1476-5381.2009.00300.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 61

  FranchimontD.MartensH.HagelsteinM. T.LouisE.DeweW.ChrousosG. P.et al (1999). Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor.J. Clin. Endocrinol. Metab.842834–2839.

  • Pubmed Abstract
  • Google Scholar

• 62

  FridovichI. (1978). The biology of oxygen radicals.Science201875–880. 10.1126/science.210504

  • CrossRef
  • Google Scholar

• 63

  FujiiT.OtaM.HoriH.HattoriK.TeraishiT.MatsuoJ.et al (2014). The common functional FKBP5 variant rs1360780 is associated with altered cognitive function in aged individuals.Sci. Rep.4:6696. 10.1038/srep06696

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 64

  GadottiV. M.ZamponiG. W. (2011). Cellular prion protein protects from inflammatory and neuropathic pain.Mol. Pain7:59. 10.1186/1744-8069-7-59

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 65

  GansnerE. R.NorthS. C. (2000). An open graph visualization system and its applications to software engineering.Softw. Pract. Exp.301203–1233. 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N

  • CrossRef
  • Google Scholar

• 66

  GarassinoM. C.PivaS.La VerdeN.SpagnolettiI.IornoV.CarboneC.et al (2013). Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.PLoS One8:e59981. 10.1371/journal.pone.0059981

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 67

  GarriockH. A.TanowitzM.KraftJ. B.DangV. C.PetersE. J.JenkinsG. D.et al (2010). Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.Am. J. Psychiatry167565–573. 10.1176/appi.ajp.2009.08081167

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 68

  GęburaK.ŚwierkotJ.WysoczańskaB.KormanL.NowakB.WilandP.et al (2017). Polymorphisms within genes involved in regulation of the NF-κB pathway in patients with rheumatoid arthritis.Int. J. Mol. Sci.18E1432. 10.3390/ijms18071432

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 69

  GendronF. P.ChalimoniukM.StrosznajderJ.ShenS.GonzalezF. A.WeismanG. A.et al (2003). P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells.J. Neurochem.87344–352. 10.1046/j.1471-4159.2003.01995.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 70

  GeorgiA.JamraR. A.KleinK.VillelaA. W.SchumacherJ.BeckerT.et al (2007). Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample.Psychiatr. Genet.17308–310. 10.1097/YPG.0b013e3280c1e5fb

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 71

  GibbsJ. E.RayD. W. (2013). The role of the circadian clock in rheumatoid arthritis.Arthritis Res. Ther.15:205. 10.1186/ar4146

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 72

  GilronI.GhasemlouN. (2014). Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain.Curr. Opin. Support. Palliat. Care8429–436. 10.1097/SPC.0000000000000085

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 73

  GoodinB. R.NessT. J.RobbinsM. T. (2015). Oxytocin – A multifunctional analgesic for chronic deep tissue pain.Curr. Pharm. Des.21906–913. 10.2174/1381612820666141027111843

  • CrossRef
  • Google Scholar

• 74

  GoodyerI. M.CroudaceT.DunnV.HerbertJ.JonesP. B. (2010). Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project.Int. J. Epidemiol.39361–369. 10.1093/ije/dyp173

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 75

  GramageE.HerradonG. (2010). Genetic deletion of pleiotrophin leads to disruption of spinal nociceptive transmission: evidence for pleiotrophin modulation of morphine-induced analgesia.Eur. J. Pharmacol.64797–102. 10.1016/j.ejphar.2010.08.029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 76

  GreenbaumL.TegederI.BarhumY.MelamedE.RoditiY.DjaldettiR. (2012). Contribution of genetic variants to pain susceptibility in Parkinson disease.Eur. J. Pain161243–1250. 10.1002/j.1532-2149.2012.00134.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 77

  GuerreroM.UrbanoM.BrownS. J.CayananC.FergusonJ.CameronM.et al (2010). “Optimization and characterization of an opioid kappa receptor (OPRK1) antagonist,” inProbe Reports from the NIH Molecular Libraries Program.Bethesda (MD): National Center for Biotechnology Information (US).

  • Google Scholar

• 78

  HackL. M.KalsiG.AlievF.KuoP.-H.PrescottC. A.PattersonD. G.et al (2011). Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish Affected Sib Pair Study of Alcohol Dependence (IASPSAD).Alcohol. Clin. Exp. Res.35376–385. 10.1111/j.1530-0277.2010.01353.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 79

  HagelbergN.ForssellH.AaltoS.RinneJ. O.ScheininH.TaiminenT.et al (2003). Altered dopamine D2 receptor binding in atypical facial pain.Pain10643–48. 10.1016/S0304-3959(03)00275-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 80

  HagelbergN.JaaskelainenS. K.MartikainenI. K.MansikkaH.ForssellH.ScheininH.et al (2004). Striatal dopamine D2 receptors in modulation of pain in humans: a review.Eur. J. Pharmacol.500187–192. 10.1016/j.ejphar.2004.07.024

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 81

  HahnW.-H.SuhJ.-S.ChoB.-S. (2011). Linkage and association study of neurotrophins and their receptors as novel susceptibility genes for childhood IgA nephropathy.Pediatr. Res.69299–305. 10.1203/PDR.0b013e31820b9365

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 82

  HausE.Sackett-LundeenL.SmolenskyM. H. (2012). Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications.Bull. NYU Hosp. Jt. Dis.70(Suppl. 1)3–10.

  • Google Scholar

• 83

  HeG.-H.CaiW.-K.ZhangJ.-B.MaC.-Y.YanF.LuJ.et al (2016). Associations of polymorphisms in HRH2, HRH3, DAO, and HNMT genes with risk of chronic heart failure.Biomed. Res. Int.2016:1208476. 10.1155/2016/1208476

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 84

  HermanA. I.BaloghK. N. (2012). Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse.Subst. Abuse Rehabil.349–57. 10.2147/SAR.S25864

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 85

  HillardC. J.WeinlanderK. M.StuhrK. L. (2012). Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Neuroscience204207–229. 10.1016/j.neuroscience.2011.11.020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 86

  HoA. M.TangN. L.CheungB. K.StadlinA. (2008). Dopamine receptor D4 gene -521C/T polymorphism is associated with opioid dependence through cold-pain responses.Ann. N. Y. Acad. Sci.113920–26. 10.1196/annals.1432.054

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 87

  HockingL. J.SmithB. H.JonesG. T.ReidD. M.StrachanD. P.MacfarlaneG. J. (2010). Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort study.Pain149143–151. 10.1016/j.pain.2010.01.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 88

  HogartA.NagarajanR. P.PatzelK. A.YasuiD. H.LasalleJ. M. (2007). 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders.Hum. Mol. Genet.16691–703. 10.1093/hmg/ddm014

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 89

  HohmannS. W.AngioniC.TunaruS.LeeS.WoolfC. J.OffermannsS.et al (2017). The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.Sci. Rep.7:446. 10.1038/s41598-017-00591-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 90

  HoughL. B.RiceF. L. (2011). H3 receptors and pain modulation: peripheral, spinal, and brain interactions.J. Pharmacol. Exp. Ther.33630–37. 10.1124/jpet.110.171264

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 91

  HuY.TangW.LiuR.DongZ.ChenX.PanM.et al (2014). Higher prevalence of migraine in essential tremor: a case-control study.Cephalalgia341142–1149. 10.1177/0333102414531153

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 92

  HuangL.AdachiN.NagaroT.LiuK.AraiT. (2007). Histaminergic involvement in neuropathic pain produced by partial ligation of the sciatic nerve in rats.Reg. Anesth Pain. Med.32124–129. 10.1097/00115550-200703000-00006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 93

  HulseR. P.DonaldsonL. F.WynickD. (2012). Peripheral galanin receptor 2 as a target for the modulation of pain.Pain Res. Treat.2012545386. 10.1155/2012/545386

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 94

  HutchinsonM. R.ZhangY.ShridharM.EvansJ. H.BuchananM. M.ZhaoT. X.et al (2010). Evidence that opioids may have toll-like receptor 4 and MD-2 effects.Brain Behav. Immun.2483–95. 10.1016/j.bbi.2009.08.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 95

  HwangI. C.ParkJ. Y.MyungS. K.AhnH. Y.FukudaK.LiaoQ. (2014). OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis.Anesthesiology121825–834. 10.1097/ALN.0000000000000405

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 96

  IdeS.NishizawaD.FukudaK.-I.KasaiS.HasegawaJ.HayashidaM.et al (2014). Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl.Mol. Pain10:75. 10.1186/1744-8069-10-75

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 97

  JaaskelainenS. K.LindholmP.ValmunenT.PesonenU.TaiminenT.VirtanenA.et al (2014). Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation.Pain1552180–2187. 10.1016/j.pain.2014.08.029

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 98

  JamesS. (2013). Human pain and genetics: some basics.Br. J. Pain7171–178. 10.1177/2049463713506408

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 99

  JayamanneA.GreenwoodR.MitchellV. A.AslanS.PiomelliD.VaughanC. W. (2006). Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.Br. J. Pharmacol.147281–288. 10.1038/sj.bjp.0706510

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 100

  JhunE.HeY.YaoY.MolokieR. E.WilkieD. J.WangZ. J. (2014). Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.Anesth. Analg.1191201–1207. 10.1213/ANE.0000000000000382

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 101

  JhunE. H.YaoY.HeY.MackA. K.WilkieD. J.MolokieR. E.et al (2015). Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease.Pharmacogenomics161795–1806. 10.2217/pgs.15.126

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 102

  JurečekováJ.BabušíkováE.Kmet’ováM.KlimentJ.DobrotaD. (2015). Estrogen receptor alpha polymorphisms and the risk of prostate cancer development.J. Cancer Res. Clin. Oncol.1411963–1971. 10.1007/s00432-015-1966-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 103

  KatusicZ. S.StelterA.MilstienS. (1998). Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells.Arterioscler. Thromb. Vasc. Biol.1827–32. 10.1161/01.ATV.18.1.27

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 104

  KaunistoM. A.JokelaR.TallgrenM.KamburO.TikkanenE.TasmuthT.et al (2013). Pain in 1000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain.Anesthesiology1191410–1421. 10.1097/ALN.0000000000000012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 105

  KhalilH.SereikaS. M.DaiF.AlexanderS.ConleyY.GruenG.et al (2017). OPRM1 and COMT gene-gene interaction is associated with postoperative pain and opioid consumption after orthopedic trauma.Biol. Res. Nurs.19170–179. 10.1177/1099800416680474

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 106

  KimH.LeeH.RowanJ.BrahimJ.DionneR. A. (2006a). Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans.Mol. Pain2:24. 10.1186/1744-8069-2-24

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 107

  KimH.MittalD. P.IadarolaM. J.DionneR. A. (2006b). Genetic predictors for acute experimental cold and heat pain sensitivity in humans.J. Med. Genet.43:e40. 10.1136/jmg.2005.036079

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 108

  KimH.NeubertJ. K.San MiguelA.XuK.KrishnarajuR. K.IadarolaM. J.et al (2004). Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament.Pain109488–496. 10.1016/j.pain.2004.02.027

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 109

  KimH. Y. (2015). Phospholipids: a neuroinflammation emerging target.Nat. Chem. Biol.1199–100. 10.1038/nchembio.1740

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 110

  KimJ. I.KimJ.-W.ParkJ.-E.ParkS.HongS.-B.HanD. H.et al (2017). Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.J. Psychopharmacol.311070–1077. 10.1177/0269881116667707

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 111

  KleinC. J.WuY.KilfoyleD. H.SandroniP.DavisM. D.GavrilovaR. H.et al (2013). Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.J. Neurol. Neurosurg. Psychiatry84386–391. 10.1136/jnnp-2012-303719

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 112

  KlepstadP.RakvagT. T.KaasaS.HoltheM.DaleO.BorchgrevinkP. C.et al (2004). The 118 A > G polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.Acta Anaesthesiol. Scand.481232–1239. 10.1111/j.1399-6576.2004.00517.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 113

  KoS. W.VadakkanK. I.AoH.Gallitano-MendelA.WeiF.MilbrandtJ.et al (2005). Selective contribution of Egr1 (zif/268) to persistent inflammatory pain.J. Pain612–20. 10.1016/j.jpain.2004.10.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 114

  KooloosW. M.WesselsJ. A.Van Der StraatenT.AllaartC. F.HuizingaT. W.GuchelaarH. J. (2010). Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.Pharmacogenomics11163–175. 10.2217/pgs.09.139

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 115

  KringelD.LötschJ. (2015). Pain research funding by the european union seventh framework programme.Eur. J. Pain19595–600. 10.1002/ejp.690

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 116

  KringelD.SisignanoM.ZinnS.LötschJ. (2017). Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq panel.PLoS One12:e0180116. 10.1371/journal.pone.0180116

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 117

  KumarD.ChakrabortyJ.DasS. (2012). Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.Prog. Neuropsychopharmacol. Biol. Psychiatry36225–230. 10.1016/j.pnpbp.2011.10.018

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 118

  KumarV.MahalB. A. (2012). NGF – The TrkA to successful pain treatment.J. Pain Res.5279–287. 10.2147/JPR.S33408

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 119

  KuritaG. P.EkholmO.KaasaS.KlepstadP.SkorpenF.SjøgrenP. (2016). Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.Brain Behav.6:e00471. 10.1002/brb3.471

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 120

  KwonH. J.JangW.-C.LimM. H. (2016). Association between RELN gene polymorphisms and attention deficit hyperactivity disorder in korean children.Psychiatry Investig.13210–216. 10.4306/pi.2016.13.2.210

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 121

  Lacroix-FralishM. L.LedouxJ. B.MogilJ. S. (2007). The pain genes database: an interactive web browser of pain-related transgenic knockout studies.Pain131e1–e4. 10.1016/j.pain.2007.04.041

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 122

  LanderE. S.LintonL. M.BirrenB.NusbaumC.ZodyM. C.BaldwinJ.et al (2001). Initial sequencing and analysis of the human genome.Nature409860–921. 10.1038/35057062

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 123

  LawP. Y.ReggioP. H.LohH. H. (2013). Opioid receptors: toward separation of analgesic from undesirable effects.Trends Biochem. Sci.38275–282. 10.1016/j.tibs.2013.03.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 124

  LedergerberC.DessimozC. (2011). Base-calling for next-generation sequencing platforms.Brief. Bioinform.12489–497. 10.1093/bib/bbq077

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 125

  LeeM.TraceyI. (2013). Neuro-genetics of persistent pain.Curr. Opin. Neurobiol.23127–132. 10.1016/j.conb.2012.11.007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 126

  LeungL.CahillC. M. (2010). TNF-alpha and neuropathic pain–a review.J. Neuroinflamm.7:27. 10.1186/1742-2094-7-27

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 127

  LiJ. Y.TaoF.WuX. X.TanY. Z.HeL.LuH. (2015). Polymorphic variations in manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) genes contribute to the development of type 2 diabetes mellitus in the Chinese Han population.Genet. Mol. Res.1412993–13002. 10.4238/2015.October.21.20

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 128

  LiT.ZhaoJ.YangJ.MaX.DaiQ.HuangH.et al (2016). A Meta-Analysis of the association between ESR1 genetic variants and the risk of breast cancer.PLoS One11:e0153314. 10.1371/journal.pone.0153314

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 129

  LinC.-H.ChaudhuriK. R.FanJ.-Y.KoC.-I.RizosA.ChangC.-W.et al (2017). Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease.Sci. Rep.7:6306. 10.1038/s41598-017-06782-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 130

  LindstedtF.KarshikoffB.SchallingM.Olgart HoglundC.IngvarM.LekanderM.et al (2012). Serotonin-1A receptor polymorphism (rs6295) associated with thermal pain perception.PLoS One7:e43221. 10.1371/journal.pone.0043221

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 131

  LippmannC.KringelD.UltschA.LötschJ. (2018). Computational functional genomics-based approaches in analgesic drug discovery and repurposing.Pharmacogenomics19783–797. 10.2217/pgs-2018-0036

  • CrossRef
  • Google Scholar

• 132

  LiuJ.ShiY.TangJ.GuoT.LiX.YangY.et al (2005). SNPs and haplotypes in the S100B gene reveal association with schizophrenia.Biochem. Biophys. Res. Commun.328335–341. 10.1016/j.bbrc.2004.12.175

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 133

  LiuY. N.YangX.SuoZ. W.XuY. M.HuX. D. (2014). Fyn kinase-regulated NMDA receptor- and AMPA receptor-dependent pain sensitization in spinal dorsal horn of mice.Eur. J. Pain181120–1128. 10.1002/j.1532-2149.2014.00455.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 134

  LoggiaM. L.ChondeD. B.AkejuO.ArabaszG.CatanaC.EdwardsR. R.et al (2015). Evidence for brain glial activation in chronic pain patients.Brain138604–615. 10.1093/brain/awu377

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 135

  LohmannK.KleinC. (2014). Next generation sequencing and the future of genetic diagnosis.Neurotherapeutics11699–707. 10.1007/s13311-014-0288-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 136

  LoncarZ.CuricG.MestrovicA. H.MickovicV.BilicM. (2013). Do IL-1B and IL-1RN modulate chronic low back pain in patients with post-traumatic stress disorder?Collegium Antropol.371237–1244.

  • Pubmed Abstract
  • Google Scholar

• 137

  LötschJ.DoehringA.MogilJ. S.ArndtT.GeisslingerG.UltschA. (2013). Functional genomics of pain in analgesic drug development and therapy.Pharmacol. Ther.13960–70. 10.1016/j.pharmthera.2013.04.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 138

  LötschJ.FluhrK.NeddermayerT.DoehringA.GeisslingerG. (2009a). The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain.Clin. Pharmacol. Ther.8525–30. 10.1038/clpt.2008.103

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 139

  LötschJ.GeisslingerG.TegederI. (2009b). Genetic modulation of the pharmacological treatment of pain.Pharmacol. Ther.124168–184. 10.1016/j.pharmthera.2009.06.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 140

  LötschJ.Von HentigN.FreynhagenR.GriessingerN.ZimmermannM.DoehringA.et al (2009c). Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.Pharmacogenet. Genom.19429–436. 10.1097/FPC.0b013e32832b89da

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 141

  LötschJ.GeisslingerG. (2005). Are mu-opioid receptor polymorphisms important for clinical opioid therapy?Trends Mol. Med.1182–89. 10.1016/j.molmed.2004.12.006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 142

  LötschJ.GeisslingerG. (2010). A critical appraisal of human genotyping for pain therapy.Trends Pharmacol. Sci.31312–317. 10.1016/j.tips.2010.04.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 143

  LötschJ.KlepstadP.DoehringA.DaleO. (2010). A GTP cyclohydrolase 1 genetic variant delays cancer pain.Pain148103–106. 10.1016/j.pain.2009.10.021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 144

  LötschJ.SipiläR.TasmuthT.KringelD.EstlanderA. M.MeretojaT.et al (2018). Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy.Breast Cancer Res./Treatment.[Epub ahead of print]. 10.1007/s10549-018-4841-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 145

  LötschJ.SkarkeC.GroschS.DarimontJ.SchmidtH.GeisslingerG. (2002). The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.Pharmacogenetics123–9. 10.1097/00008571-200201000-00002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 146

  LötschJ.StuckB.HummelT. (2006). The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation.Behav. Neurosci.1201218–1224. 10.1037/0735-7044.120.6.1218

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 147

  LuH.ZhuL.LianL.ChenM.ShiD.WangK. (2015). Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.Tumour Biol.365241–5247. 10.1007/s13277-015-3182-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 148

  MaertensO.De SchepperS.VandesompeleJ.BremsH.HeynsI.JanssensS.et al (2007). Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.Am. J. Hum. Genet.81243–251. 10.1086/519562

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 149

  MansourA. R.FarmerM. A.BalikiM. N.ApkarianA. V. (2014). Chronic pain: the role of learning and brain plasticity.Restor. Neurol. Neurosci.32129–139.

  • Google Scholar

• 150

  MarcosM.PastorI.De La CalleC.Barrio-RealL.LasoF.-J.González-SarmientoR. (2012). Cannabinoid receptor 1 gene is associated with alcohol dependence.Alcohol. Clin. Exp. Res.36267–271. 10.1111/j.1530-0277.2011.01623.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 151

  MartikainenI. K.NuechterleinE. B.PecinaM.LoveT. M.CummifordC. M.GreenC. R.et al (2015). Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum.J. Neurosci.359957–9965. 10.1523/JNEUROSCI.4605-14.2015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 152

  MaxwellJ. R.PotterC.HyrichK. L.BartonA.WorthingtonJ.IsaacsJ. D.et al (2008). Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.Hum. Mol. Genet.173532–3538. 10.1093/hmg/ddn245

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 153

  McIntoshA. M.SimenA. A.EvansK. L.HallJ.MacintyreD. J.BlackwoodD.et al (2012). Genetic variation in hyperpolarization-activated cyclic nucleotide-gated channels and its relationship with neuroticism, cognition and risk of depression.Front. Genet.3:116. 10.3389/fgene.2012.00116

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 154

  MeadS.PoulterM.UphillJ.BeckJ.WhitfieldJ.WebbT. E. F.et al (2009). Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.Lancet Neurol.857–66. 10.1016/S1474-4422(08)70265-5

  • CrossRef
  • Google Scholar

• 155

  MetzkerM. L. (2010). Sequencing technologies – The next generation.Nat. Rev. Genet.1131–46. 10.1038/nrg2626

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 156

  MillJ.KissE.BajiI.KapornaiK.DaróczyG.VetróA.et al (2008). Association study of the estrogen receptor alpha gene (ESR1) and childhood-onset mood disorders.Am. J. Med. Genet. B Neuropsychiatr. Genet.147B1323–1326. 10.1002/ajmg.b.30751

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 157

  MilneR. L.BurwinkelB.MichailidouK.Arias-PerezJ.-I.ZamoraM. P.Menéndez-RodríguezP.et al (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer association consortium.Hum. Mol. Genet.236096–6111. 10.1093/hmg/ddu311

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 158

  MitraA. K.CrewsK.PoundsS.CaoX.DowningJ. R.RaimondiS.et al (2011). Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study.Leukemia251354–1356. 10.1038/leu.2011.74

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 159

  MocellinS.MarincolaF.RossiC. R.NittiD.LiseM. (2004). The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle.Cytokine Growth. Factor. Rev.1561–76. 10.1016/j.cytogfr.2003.11.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 160

  MogilJ. S. (2009). Are we getting anywhere in human pain genetics?Pain146231–232. 10.1016/j.pain.2009.07.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 161

  MogilJ. S. (2012). Pain genetics: past, present and future.Trends Genet.28258–266. 10.1016/j.tig.2012.02.004

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 162

  MustafaA. E.FaquihT.BazB.KattanR.Al-IssaA.TahirA. I.et al (2018). Validation of ion torrent(TM) inherited disease panel with the PGM(TM) sequencing platform for rapid and comprehensive mutation detection.Genes (Basel.)9267. 10.3390/genes9050267

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 163

  NackleyA. G.ShabalinaS. A.TchivilevaI. E.SatterfieldK.KorchynskyiO.MakarovS. S.et al (2006). Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.Science3141930–1933. 10.1126/science.1131262

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 164

  NaumovD. E.PerelmanJ. M.KolosovV. P.PotapovaT. A.MaksimovV. N.ZhouX. (2015). Transient receptor potential melastatin 8 gene polymorphism is associated with cold-induced airway hyperresponsiveness in bronchial asthma.Respirology201192–1197. 10.1111/resp.12605

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 165

  NemethE.RiveraS.GabayanV.KellerC.TaudorfS.PedersenB. K.et al (2004). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.J. Clin. Invest.1131271–1276. 10.1172/JCI200420945

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 166

  NichollB. I.HollidayK. L.MacfarlaneG. J.ThomsonW.DaviesK. A.O’neillT. W.et al (2011). Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts.Arthritis Rheum.63810–818. 10.1002/art.30185

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 167

  NissenbaumJ.DevorM.SeltzerZ.GebauerM.MichaelisM.TalM.et al (2010). Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2.Genome Res.201180–1190. 10.1101/gr.104976.110

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 168

  NöthenM. M.CichonS.HemmerS.HebebrandJ.RemschmidtH.LehmkuhlG.et al (1994). Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity.Hum. Mol. Genet.32207–2212. 10.1093/hmg/3.12.2207

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 169

  ObataK.NoguchiK. (2006). BDNF in sensory neurons and chronic pain.Neurosci. Res.551–10. 10.1016/j.neures.2006.01.005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 170

  OertelB. G.DoehringA.RoskamB.KettnerM.HackmannN.FerreirosN.et al (2012). Genetic-epigenetic interaction modulates mu-opioid receptor regulation.Hum. Mol. Genet.214751–4760. 10.1093/hmg/dds314

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 171

  OertelB. G.SchmidtR.SchneiderA.GeisslingerG.LötschJ. (2006). The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.Pharmacogenet. Genom.16625–636. 10.1097/01.fpc.0000220566.90466.a2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 172

  OffenbaecherM.BondyB.De JongeS.GlatzederK.KrugerM.SchoepsP.et al (1999). Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region.Arthritis Rheum.422482–2488. 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 173

  OnayaT.IshiiM.KatohH.ShimizuS.KasaiH.KawamuraM.et al (2013). Predictive index for the onset of medication overuse headache in migraine patients.Neurol. Sci.3485–92. 10.1007/s10072-012-0955-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 174

  OnojjighofiaT.MeshkinB.NguyenS. V.SchwartzD.AkindeleB. (2014). Perception of analgesia in narcotic users with chronic pain: a multi-center cross-sectional study comparing genotype to pain VAS (P.A.I.N. Study).Neurology82:E39.

  • Google Scholar

• 175

  Oyanguren-DesezO.Rodríguez-AntigüedadA.VillosladaP.DomercqM.AlberdiE.MatuteC. (2011). Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.Cell Calcium50468–472. 10.1016/j.ceca.2011.08.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 176

  PalmirottaR.BarbantiP.De MarchisM. L.EgeoG.AuriliaC.FofiL.et al (2015). Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?Antioxid. Redox Signal.22275–279. 10.1089/ars.2014.6069

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 177

  ParkJ. J.LeeJ.KimM. A.BackS. K.HongS. K.NaH. S. (2007). Induction of total insensitivity to capsaicin and hypersensitivity to garlic extract in human by decreased expression of TRPV1.Neurosci. Lett.41187–91. 10.1016/j.neulet.2006.10.046

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 178

  PeiroA. M.PlanellesB.JuhaszG.BagdyG.LibertF.EschalierA.et al (2016). Pharmacogenomics in pain treatment.Drug Metab. Pers Ther.31131–142. 10.1515/dmpt-2016-0005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 179

  PelletierC.WeidhaasJ. B. (2010). MicroRNA binding site polymorphisms as biomarkers of cancer risk.Expert. Rev. Mol. Diagn.10817–829. 10.1586/erm.10.59

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 180

  PetrenkoA. B.YamakuraT.BabaH.ShimojiK. (2003). The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review.Anesth. Analg.971108–1116. 10.1213/01.ANE.0000081061.12235.55

  • CrossRef
  • Google Scholar

• 181

  PotapovaT. A.BabenkoV. N.KobzevV. F.RomashchenkoA. G.MaksimovV. N.VoevodaM. I. (2014). Associations of cold receptor TRPM8 gene single nucleotide polymorphism with blood lipids and anthropometric parameters in Russian population.Bull. Exp. Biol. Med.157757–761. 10.1007/s10517-014-2660-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 182

  PotvinS.LaroucheA.NormandE.De SouzaJ. B.GaumondI.GrignonS.et al (2009). DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls.J. Pain10969–975. 10.1016/j.jpain.2009.03.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 183

  PrasadH. C.SteinerJ. A.SutcliffeJ. S.BlakelyR. D. (2009). Enhanced activity of human serotonin transporter variants associated with autism.Philos. Trans. R. Soc. Lond. B Biol. Sci.364163–173. 10.1098/rstb.2008.0143

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 184

  R Development Core Team (2008). R: A Language and Environment for Statistical Computing.Vienna: R Development Core Team.

  • Google Scholar

• 185

  RakvagT. T.KlepstadP.BaarC.KvamT. M.DaleO.KaasaS.et al (2005). The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.Pain11673–78. 10.1016/j.pain.2005.03.032

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 186

  ReimannF.CoxJ. J.BelferI.DiatchenkoL.ZaykinD. V.MchaleD. P.et al (2010). Pain perception is altered by a nucleotide polymorphism in SCN9A.Proc. Natl. Acad. Sci. U.S.A.1075148–5153. 10.1073/pnas.0913181107

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 187

  Reyes-GibbyC. C.SheteS.RakvagT.BhatS. V.SkorpenF.BrueraE.et al (2007). Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.Pain13025–30. 10.1016/j.pain.2006.10.023

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 188

  Ribeiro-DasilvaM. C.Peres LineS. R.Leme GodoyDos SantosM. C.ArthuriM. T.HouW.et al (2009). Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder.J. Pain10527–533. 10.1016/j.jpain.2008.11.012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 189

  RodriguesP.De MarcoG.FurriolJ.MansegoM. L.Pineda-AlonsoM.Gonzalez-NeiraA.et al (2014). Oxidative stress in susceptibility to breast cancer: study in Spanish population.BMC Cancer14:861. 10.1186/1471-2407-14-861

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 190

  RootT. L.SzatkiewiczJ. P.JonassaintC. R.ThorntonL. M.PinheiroA. P.StroberM.et al (2011). Association of candidate genes with phenotypic traits relevant to anorexia nervosa.Eur. Eat Disord. Rev.19487–493. 10.1002/erv.1138

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 191

  SahD. W.OssipovM. H.RossomandoA.SilvianL.PorrecaF. (2005). New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors.Curr. Top. Med. Chem.5577–583. 10.2174/1568026054367593

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 192

  SangerF.CoulsonA. R. (1975). A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.J. Mol. Biol.94441–448. 10.1016/0022-2836(75)90213-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 193

  SangerF.NicklenS.CoulsonA. R. (1977). DNA sequencing with chain-terminating inhibitors.Proc. Natl. Acad. Sci. U.S.A.745463–5467. 10.1073/pnas.74.12.5463

  • CrossRef
  • Google Scholar

• 194

  SatoM.OhashiJ.TsuchiyaN.KashiwaseK.IshikawaY.AritaH.et al (2002). Association of HLA-A^∗3303-B^∗4403-DRB1^∗1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese population.Genes Immun.3477–481. 10.1038/sj.gene.6363890

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 195

  SavasS.SchmidtS.JarjanaziH.OzcelikH. (2006). Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.Hum. Genomics2287–296. 10.1186/1479-7364-2-5-287

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 196

  SchleinitzD.CarmienkeS.BöttcherY.TönjesA.BerndtJ.KlötingN.et al (2010). Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity.Pharmacogenomics11693–702. 10.2217/pgs.10.42

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 197

  SchmidtS.HauserM. A.ScottW. K.PostelE. A.AgarwalA.GallinsP.et al (2006). Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.Am. J. Hum. Genet.78852–864. 10.1086/503822

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 198

  SchottK.GutlichM.ZieglerI. (1993). Induction of GTP-cyclohydrolase I mRNA expression by lectin activation and interferon-gamma treatment in human cells associated with the immune response.J. Cell. Physiol.15612–16. 10.1002/jcp.1041560103

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 199

  SchurksM.KurthT.BuringJ. E.ZeeR. Y. (2009). A candidate gene association study of 77 polymorphisms in migraine.J. Pain10759–766. 10.1016/j.jpain.2009.01.326

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 200

  SchürksM.RistP. M.KurthT. (2010). Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis.Cephalalgia301306–1328. 10.1177/0333102410364155

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 201

  SchützM.OertelB. G.HeimannD.DoehringA.WalterC.DimovaV.et al (2014). Consequences of a human TRPA1 genetic variant on the perception of nociceptive and olfactory stimuli.PLoS One9:e95592. 10.1371/journal.pone.0095592

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 202

  SchwartzE. S.KimH. Y.WangJ.LeeI.KlannE.ChungJ. M.et al (2009). Persistent pain is dependent on spinal mitochondrial antioxidant levels.J. Neurosci.29159–168. 10.1523/JNEUROSCI.3792-08.2009

  • CrossRef
  • Google Scholar

• 203

  SchweinhardtP.SauroK. M.BushnellM. C. (2008). Fibromyalgia: a disorder of the brain?Neuroscientist14415–421. 10.1177/1073858407312521

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 204

  SerýO.PrikrylR.CastulíkL.St’astnýF. (2010). A118G polymorphism of OPRM1 gene is associated with schizophrenia.J. Mol. Neurosci.41219–222. 10.1007/s12031-010-9327-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 205

  ShahN. D.ShahP. S.PanchalY. Y.KatudiaK. H.KhatriN. B.RayH. S. P.et al (2018). Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.Appl. Clin. Genet.1159–67. 10.2147/TACG.S155955

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 206

  SherryS. T.WardM. H.KholodovM.BakerJ.PhanL.SmigielskiE. M.et al (2001). dbSNP: the NCBI database of genetic variation.Nucleic Acids Res.29308–311. 10.1093/nar/29.1.308

  • CrossRef
  • Google Scholar

• 207

  ShiJ.BadnerJ. A.HattoriE.PotashJ. B.WillourV. L.McmahonF. J.et al (2008). Neurotransmission and bipolar disorder: a systematic family-based association study.Am. J. Med. Genet. B Neuropsychiatr. Genet.147B1270–1277. 10.1002/ajmg.b.30769

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 208

  ShiT.-J. S.LiuS.-X. L.HammarbergH.WatanabeM.XuZ.-Q. D.HökfeltT. (2008). Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.Proc. Natl. Acad. Sci. U.S.A.10520004–20008. 10.1073/pnas.0810899105

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 209

  ShoskesD. A.AlbakriQ.ThomasK.CookD. (2002). Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.J. Urol.168331–335. 10.1016/S0022-5347(05)64916-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 210

  SiqueiraE. C. D.De SousaS. F.FrançaJ. A.DinizM. G.PereiraT. D. S. F.MoreiraR. G.et al (2017). Targeted next-generation sequencing of glandular odontogenic cyst: a preliminary study.Oral. Surg. Oral Med. Oral. Pathol. Oral Radiol.124490–494. 10.1016/j.oooo.2017.07.001

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 211

  SkarkeC.KirchhofA.GeisslingerG.LötschJ. (2004). Comprehensive mu-opioid-receptor genotyping by pyrosequencing.Clin. Chem.50640–644. 10.1373/clinchem.2003.027607

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 212

  SkarkeC.KirchhofA.GeisslingerG.LötschJ. (2005). Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.Eur. J. Clin. Pharmacol.61887–892. 10.1007/s00228-005-0029-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 213

  SlukaK. A.AudetteK. M. (2006). Activation of protein kinase C in the spinal cord produces mechanical hyperalgesia by activating glutamate receptors, but does not mediate chronic muscle-induced hyperalgesia.Mol. Pain2:13. 10.1186/1744-8069-2-13

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 214

  SmithF. L.FujimoriK.LoweJ.WelchS. P. (1998). Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.Pharmacol. Biochem. Behav.60183–191. 10.1016/S0091-3057(97)00583-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 215

  SniderW. D.McMahonS. B. (1998). Tackling pain at the source: new ideas about nociceptors.Neuron20629–632. 10.1016/S0896-6273(00)81003-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 216

  SolusJ. F.ChungC. P.OeserA.LiC.RhoY. H.BradleyK. M.et al (2015). Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.Clin. Rheumatol.341375–1382. 10.1007/s10067-015-2881-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 217

  SomogyiA. A.CollerJ. K.BarrattD. T. (2015). Pharmacogenetics of opioid response.Clin. Pharmacol. Ther.97125–127. 10.1002/cpt.23

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 218

  SomogyiA. A.SiaA. T.TanE.-C.CollerJ. K.HutchinsonM. R.BarrattD. T. (2016). Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative pain.Pain1572458–2466. 10.1097/j.pain.0000000000000661

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 219

  SonodaT.TakadaJ.IbaK.AsakuraS.YamashitaT.MoriM. (2012). Interaction between ESRα polymorphisms and environmental factors in osteoporosis.J. Orthop. Res.301529–1534. 10.1002/jor.22083

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 220

  SorgeR. E.TrangT.DorfmanR.SmithS. B.BeggsS.RitchieJ.et al (2012). Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.Nat. Med.18595–599. 10.1038/nm.2710

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 221

  StephensK.CooperB. A.WestC.PaulS. M.BaggottC. R.MerrimanJ. D.et al (2014). Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.J. Pain15169–180. 10.1016/j.jpain.2013.09.015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 222

  SugayaK.NishijimaS.YamadaT.MiyazatoM.HatanoT.OgawaY. (2002). Molecular analysis of adrenergic receptor genes and interleukin-4/interleukin-4 receptor genes in patients with interstitial cystitis.J. Urol.1682668–2671. 10.1016/S0022-5347(05)64241-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 223

  SunY.-G.GraciasN. G.DrobishJ. K.VaskoM. R.GereauR. W.ChenZ.-F. (2009). The c-kit signaling pathway is involved in the development of persistent pain.Pain144178–186. 10.1016/j.pain.2009.04.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 224

  TegederI.CostiganM.GriffinR. S.AbeleA.BelferI.SchmidtH.et al (2006). GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.Nat. Med.121269–1277. 10.1038/nm1490

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 225

  ThuaultS. (2016). A peripheral messenger for chronic pain.Nat. Neurosci.19:9. 10.1038/nn.4217

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 226

  ThulasiramanK.SwamyM. N. S. (1992). Graphs : Theory and Algorithms.New York, NY: Wiley. 10.1002/9781118033104

  • CrossRef
  • Google Scholar

• 227

  TianW.FuY.Garcia-EliasA.Fernández-FernándezJ. M.VicenteR.KramerP. L.et al (2009). A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.Proc. Natl. Acad. Sci. U.S.A.10614034–14039. 10.1073/pnas.0904084106

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 228

  TsaiS.-J.HongC.-J.ChengC.-Y.LiaoD.-L.LiouY.-J. (2007). Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.J. Neural Transm. (Vienna)114423–426. 10.1007/s00702-006-0587-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 229

  TsantoulasC.MooneyE. R.McnaughtonP. A. (2016). HCN2 ion channels: basic science opens up possibilities for therapeutic intervention in neuropathic pain.Biochem. J.4732717–2736. 10.1042/BCJ20160287

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 230

  TulahA. S.BegheB.BartonS. J.HollowayJ. W.SayersI. (2012). Leukotriene B4 receptor locus gene characterisation and association studies in asthma.BMC Med. Genet.13:110. 10.1186/1471-2350-13-110

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 231

  UltschA.KringelD.KalsoE.MogilJ. S.LötschJ. (2016). A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity.Pain1572747–2757. 10.1097/j.pain.0000000000000694

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 232

  UrsuD.EbertP.LangronE.RubleC.MunsieL.ZouW.et al (2014). Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.Mol Pain10:37. 10.1186/1744-8069-10-37

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 233

  VaclavikovaE.DvorakovaS.SkabaR.PosL.SykorovaV.HalkovaT.et al (2014). RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.PLoS One9:e98957. 10.1371/journal.pone.0098957

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 234

  VadakkanK. I.WangH.KoS. W.ZastepaE.PetrovicM. J.SlukaK. A.et al (2006). Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl yclases.Mol. Pain2:7. 10.1186/1744-8069-2-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 235

  VassalliP. (1992). The pathophysiology of tumor necrosis factors.Annu. Rev. Immunol.10411–452. 10.1146/annurev.iy.10.040192.002211

  • CrossRef
  • Google Scholar

• 236

  VennJ. (1880). On the diagrammatic and mechanical representation of propositions and reasonings.Dublin Philos. Mag. J. Sci.91–18. 10.1080/14786448008626877

  • CrossRef
  • Google Scholar

• 237

  VenterJ. C.AdamsM. D.MyersE. W.LiP. W.MuralR. J.SuttonG. G.et al (2001). The sequence of the human genome.Science2911304–1351. 10.1126/science.1058040

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 238

  WalkerK.BowesM.PanesarM.DavisA.GentryC.KesinglandA.et al (2001). Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.Neuropharmacology401–9. 10.1016/S0028-3908(00)00113-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 239

  WalterC.DoehringA.OertelB. G.LötschJ. (2013). μ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain.Pharmacogenomics141915–1925. 10.2217/pgs.13.187

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 240

  WangC.WangH.PangJ.LiL.ZhangS.SongG.et al (2014). Glial cell-derived neurotrophic factor attenuates neuropathic pain in a mouse model of chronic constriction injury: possible involvement of E-cadherin/p120ctn signaling.J. Mol. Neurosci.54156–163. 10.1007/s12031-014-0266-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 241

  WangX.-S.SongH.-B.ChenS.ZhangW.LiuJ.-Q.HuangC.et al (2015). Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.J. Huazhong Univ. Sci. Technolog. Med. Sci.35752–758. 10.1007/s11596-015-1502-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 242

  WedrénS.LovmarL.HumphreysK.MagnussonC.MelhusH.SyvänenA.-C.et al (2008). Estrogen receptor alpha gene polymorphism and endometrial cancer risk–a case-control study.BMC Cancer8:322. 10.1186/1471-2407-8-322

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 243

  Wellcome Trust Case Control and Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.Nature447661–678. 10.1038/nature05911

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 244

  WiseB. L.DemissieS.CupplesL. A.FelsonD. T.YangM.ShearmanA. M.et al (2009). The relationship of estrogen receptor-alpha and -beta genes with osteoarthritis of the hand.J. Rheumatol.362772–2779. 10.3899/jrheum.081208

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 245

  WoltersP. L.BurnsK. M.MartinS.BaldwinA.DombiE.Toledo-TamulaM. A.et al (2015). Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.Am. J. Med. Genet. A167A2103–2113. 10.1002/ajmg.a.37123

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 246

  WooJ. H.KimH.KimJ. H.KimJ. G. (2015). Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.Menopause22512–519. 10.1097/GME.0000000000000339

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 247

  YamamotoM.ItoY.MitsumaN.HattoriN.SobueG. (2003). Pain-related differential expression of NGF, GDNF, IL-6, and their receptors in human vasculitic neuropathies.Intern. Med.421100–1103. 10.2169/internalmedicine.42.1100

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 248

  YangL.GuX.ZhangW.ZhangJ.MaZ. (2014). Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.Neurol. Sci.351365–1371. 10.1007/s10072-014-1713-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 249

  YücelY.CoşkunS.CengizB.ÖzdemirH. H.UzarE.ÇimA.et al (2016). Association of polymorphisms within the serotonin receptor genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and migraine susceptibility in a turkish population.Clin. Psychopharmacol. Neurosci.14250–255. 10.9758/cpn.2016.14.3.250

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 250

  YucesoyB.JohnsonV. J.LummusZ. L.KisslingG. E.FluhartyK.GautrinD.et al (2012). Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.Toxicol. Sci.129166–173. 10.1093/toxsci/kfs183

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 251

  ZanetteS. A.Dussan-SarriaJ. A.SouzaA.DeitosA.TorresI. L. S.CaumoW. (2014). Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia.Mol. Pain10:46. 10.1186/1744-8069-10-46

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 252

  ZhangL.RaoF.ZhangK.KhandrikaS.DasM.VaingankarS. M.et al (2007). Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.J. Clin. Invest.1172658–2671. 10.1172/JCI31093

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 253

  ZinnS.SisignanoM.KernK.PierreS.TunaruS.JordanH.et al (2017). The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.J. Biol. Chem.2926123–6134. 10.1074/jbc.M116.769125

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 254

  Zorina-LichtenwalterK.MelotoC. B.KhouryS.DiatchenkoL. (2016). Genetic predictors of human chronic pain conditions.Neuroscience33836–62. 10.1016/j.neuroscience.2016.04.041

  • Pubmed Abstract
  • CrossRef
  • Google Scholar